home *** CD-ROM | disk | FTP | other *** search
- TABLE 34-12. Results of Randomized Trials in Patients With Poor-Risk
- Germ Cell Tumors
-
- P, cisplatin 100 mg/m**2; P(200), cisplatin 200 mg/m**2; V,
- vinblastine; B, bleomycin; E, etoposide; O, vincristine; I,
- ifosfamide; NS, not stated; EORTC, European Organization for the
- Research and Treatment of Cancer; NCI, National Cancer Institute; MRC,
- Medical Research Council; SWOG, Southwest Oncology Group.
- *Subset analysis only. No difference in the clinical trial as a whole.
-